Clinical Trial Update: Influence of CYP2C9 Genotype on Clinical Efficacy of Tenoxicam [Phase 4]

View source ↗

Summary

Phase 4 trial update examining how CYP2C9 genotype may influence the clinical efficacy of Tenoxicam.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Molar Pain
• Pain

Drugs mentioned

• Tenoxicam (tenoxicam)

Snippet

Sponsor: University of Sao Paulo | Conditions: Molar, Third, Pain | Phase 4 | Status: COMPLETED